Top Tweets for #arcutis
Arcutis’ ZORYVE® (roflumilast) Topical Foam 0.3% Approved by U.S. FDA for the Treatment of Plaque Psoriasis in Adults and Adolescents Ages 12 and Older $ARQT https://t.co/UJ6eL5Uv1t

Arcutis announces public offering of common stock to strengthen its balance sheet for the launch of the Company’s first FDA approved product and continued advancement of its pipeline. #Arcutis $ARQT https://t.co/Vyu4rP5sOK

Patients suffering from #skindiseases deserve treatments that do not compromise between drug safety, efficacy, and tolerability. Meet the #dermatology clinicians at #Arcutis who are dedicated to making a difference for patients.

Spotted: the #Arcutis team at our first LIVE Medical Affairs exhibit booth of 2021 at @MauiDerm! We’re just a little excited 😊
Stop by to learn more about us, our pipeline, and work in #dermatology.

Patients living with #seborrheicdermatitis deserve treatments that don’t make tradeoffs between efficacy, safety and tolerability for chronic use. Read here how #Arcutis is committed to creating a solution for #sebderm patients everywhere: https://t.co/ina285meqO
We are thrilled to welcome Raj Madan as our first Chief Digital and Information Officer to #Arcutis! To learn about the dynamic and unique expertise of our leadership team, visit: https://t.co/XIqPrtCimo #medicaldermatology #derm

Latest headline: $ARQT: Arcutis Enrolls Last Patient in Phase 2b Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Scalp Psoriasis
https://t.co/TTlX0FzZ77
#stockstowatch #premarket #DayTrading #NASDAQ #Arcutis
Latest headline: $ARQT: The New England Journal of Medicine Publishes Results from Positive Phase 2b Trial of Arcutis’ ARQ-151 (Topical Roflumilast Cream) for the Treatment of Chronic Plaque Psoriasis
https://t.co/NpaMTuYfhL
#stockstowatch #premarket #NASDAQ #Arcutis
Latest headline: $ARQT: Arcutis Initiates Patient Enrollment in the Phase 2b Portion of the Phase 1/2b Study Evaluating ARQ-252 in Chronic Hand Eczema
https://t.co/GTnvugfUej
#stockstowatch #premarket #DayTrading #NASDAQ #Arcutis
Most Popular Users

Elon Musk 
@elonmusk
240.7M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.5M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.4M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers







